Diverse in skills, background and experience, working in a variety of functions around the world, we at Johnson & Johnson are united by our common passion for patient care. This core value is captured by Our Credo, which defines the fundamental values that unite all J&J employees: we put the people we serve first. Our Credo guides every decision we make and challenges us to keep patients and their families as our primary focus.
The Johnson & Johnson Family of Companies is the largest and most diverse healthcare company, covering consumer healthcare, medical devices and pharmaceticals business segments. We are committed to continuous innovation, with a track record for developing a wide array of innovative healthcare products and solutions.
Revolutionizing disease treatment. Three J&J drugs were granted an accelerated review time to approval (FDA Breakthrough Therapy designation). The drugs demonstrate substantial improvement over existing therapies early in clinical development, and FDA committed to expedited development of these breakthrough drugs addressing multiple myeloma, treatment-resistant depression and chronic lymphocytic leukemia. We also developed the first drug with a novel mechanism of action for tuberculosis in over 40 years.
Innovation in surgery to save lives. J&J is committed to advancing surgical care, with an extensive, innovative wound-closure portfolio with over 200 different suture needles. A strategic collaboration with Google, Inc. focuses on the creation of an innovative robotic-assisted surgical platform capable of integrating advanced technologies and supporting surgeons in the operating room.
Predicting and preempting disease. We innovate through new approaches. Disease Interception (DI) intervenes earlier than today’s clinically accepted point of diagnosis to stop, reverse or inhibit progression to disease..
We serve millions of patients worldwide by addressing truly unmet medical needs. In 2015, the World Health Organization added 3 of our life-saving medicines to its list of Essential Medicines bringing the total number of our medicines on WHO’s list to 8.
Our Ethical Code for the Conduct of Research and Development provides specific, global standards of conduct and behavior for physicians responsible for medical aspects of research and development.
The Yale Open Data Access (YODA) Project is enabling scientists around the world to gain access to our company’s clinical trial data. J&J is the first company to collaborate with and give decision rights to an independent third party to allow access to clinical research data and findings. This project aims to advance science and research, the foundation of medical care.
The broad scope of Johnson & Johnson results in wide-ranging career opportunities across the company. Our colleagues have opportunities to take on new challenges, to grow and to advance in a range of health-related areas.
Throughout our three business segments, physicians can expand their career into a variety of areas such as R&D, Medical Affairs, Global Public Health and Medical Safety. They can work on different disease areas and contribute to innovative products − both in our development pipeline and on the market.
A number of internal programs offer opportunities to develop leadership skills and collaborate on highly talented, innovative teams that enable broad-based, global approaches to research and innovation.
Collaboration. Connection. Patient impact on a global scale. Explore career opportunities for physicians at Johnson & Johnson.